Page last updated: 2024-09-03

tazobactam and achn 490

tazobactam has been researched along with achn 490 in 2 studies

Compound Research Comparison

Studies
(tazobactam)
Trials
(tazobactam)
Recent Studies (post-2010)
(tazobactam)
Studies
(achn 490)
Trials
(achn 490)
Recent Studies (post-2010) (achn 490)
1,32715369483775

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A1
Garcia, JA; Liang, SY; Long, B; Matlock, A; Moussavi, K1

Reviews

2 review(s) available for tazobactam and achn 490

ArticleYear
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines

2020
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.
    Internal and emergency medicine, 2021, Volume: 16, Issue:8

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem; Sisomicin; Tazobactam; Tetracyclines

2021